15.2 QAPI Programs, PDSA Cycles & the ESRD Quality Incentive Program
Key Takeaways
42 CFR 494.110 requires a data-driven QAPI program, with IDT participation, that tracks dialysis adequacy, nutritional status, mineral metabolism, anemia, vascular access, medical errors, reuse, patient satisfaction and infection control.
The ESRD Quality Incentive Program, created by MIPPA 2008 section 153(c), cuts a low-scoring facility's Medicare ESRD PPS payments by 0.5% to 2.0% for the payment year.
In the PY 2028 ESRD QIP, Hypercalcemia is a reporting measure credited for entering total uncorrected calcium values in EQRS.
CMS proposed in June 2026 to replace the Hypercalcemia reporting measure with a chronic hyperphosphatemia clinical measure starting in PY 2029; this is not final until the final rule is issued.
A PDSA cycle tests a change on a small scale first (Plan, Do, Study, Act) before adopting it facility-wide.
Two layers of quality in dialysis
Quality oversight in dialysis runs on two linked tracks:
- Quality Assessment and Performance Improvement (QAPI) is an internal program every facility must run under the Conditions for Coverage (42 CFR 494.110).
- The ESRD Quality Incentive Program (ESRD QIP) is Medicare's pay-for-performance program under section 1881(h) of the Social Security Act, added by section 153(c) of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA).
The CSR outline lists quality improvement in Domain 3, and a task statement asks you to participate with the IDT to identify areas that need improvement and to develop, implement and evaluate plans to achieve that improvement (e.g., QAPI).
The QAPI condition (§494.110)
The facility must "develop, implement, maintain, and evaluate an effective, data-driven" QAPI program with participation by the professional members of the IDT. The program must focus on indicators linked to better health outcomes and to preventing and reducing medical errors, and the facility must be able to show CMS evidence of it.
Required indicators (§494.110(a)(2))
The program must measure, analyze and track, at a minimum:
- adequacy of dialysis;
- nutritional status;
- mineral metabolism and renal bone disease;
- anemia management;
- vascular access;
- medical injuries and medical errors;
- the hemodialyzer reuse program, if dialyzers are reused;
- patient satisfaction and grievances; and
- infection control, including analyzing infection trends, promoting immunization and acting to reduce future infections.
Monitoring and priorities (§494.110(b)–(c))
The facility must monitor performance continuously, act to improve it, and track results to make sure improvements last. Priorities are set by the prevalence and severity of problems, with preference for activities that affect clinical outcomes or patient safety. Problems that threaten health and safety must be corrected immediately. The regulation does not set a meeting schedule. Most facilities review QAPI data monthly, and surveyors expect regular, documented review.
What the dietitian brings to QAPI
The dietitian leads or co-leads the nutrition and mineral-metabolism indicators. Examples include the share of patients with albumin below target, phosphorus above 7.0 mg/dL, IDWG above 5%, or low nPCR. The dietitian analyzes causes and designs interventions. The CMS Measures Assessment Tool lists albumin 4.0 g/dL or higher by bromocresol green (BCG), or the lab's normal range if bromocresol purple (BCP) is used, as the albumin outcome value, and tells facilities to set aggregate goals using their ESRD Network's targets.
The Plan-Do-Study-Act (PDSA) cycle
PDSA is the small-test-of-change method most dialysis QAPI programs use:
- Plan: Define the problem with data, analyze root causes (fishbone diagram or "5 whys"), set a SMART aim and predict the result.
- Do: Test the change on a small scale (one shift, one pod) and collect process and outcome data.
- Study: Compare results with the prediction and the baseline.
- Act: Adopt, adapt or abandon the change, then plan the next cycle.
Worked example. A monthly QAPI review shows 34% of in-center patients with phosphorus above 7.0 mg/dL.
- Root causes found: binders taken at bedtime, no binders with chairside snacks, and phosphate-additive fast food bought on dialysis days.
- Aim: reduce the share of Shift 1 patients with phosphorus above 7.0 mg/dL from 34% to below 20% within 8 weeks.
- Do: pictorial binder-meal cards; technicians prompt binder use with chairside snacks; a 10-minute "additive detective" label session.
- Study: after two monthly lab cycles, Shift 1 falls to 18%, and binder-with-meal adherence rises from 42% to 81%.
- Act: adopt the protocol for all shifts and add it to staff onboarding.
The ESRD Quality Incentive Program
The ESRD QIP adjusts Medicare ESRD PPS payments based on performance. Each facility gets a Total Performance Score (TPS) from 0 to 100. A facility whose TPS falls below the minimum set for that payment year has its payments reduced for the whole year on a sliding scale, up to 2%:
| TPS relative to the minimum | Payment reduction |
|---|---|
| At or above the minimum | None |
| 1–10 points below | 0.5% |
| 11–20 points below | 1.0% |
| 21–30 points below | 1.5% |
| 31 or more points below | 2.0% |
Results are public, and facility scores also appear on Dialysis Facility Care Compare.
The PY 2028 measure set (finalized in the CY 2026 ESRD PPS rule; performance year 2026)
| Measure | Type |
|---|---|
| In-Center Hemodialysis CAHPS (shortened to 39 questions from PY 2028) | Clinical |
| Standardized Readmission Ratio; Standardized Hospitalization Ratio; Standardized Transfusion Ratio | Clinical |
| Kt/V Dialysis Adequacy measure topic (adult HD, adult PD, pediatric HD, pediatric PD) | Clinical |
| Hemodialysis Vascular Access: Long-Term Catheter Rate | Clinical |
| Clinical Depression Screening and Follow-Up | Clinical |
| NHSN Bloodstream Infection in Hemodialysis Patients | Clinical |
| Percentage of Prevalent Patients Waitlisted (PPPW) | Clinical |
| Hypercalcemia: percentage of patient-months with a total uncorrected serum or plasma calcium value reported in EQRS | Reporting |
| Medication Reconciliation (MedRec) | Reporting |
| COVID-19 Vaccination Coverage Among Healthcare Personnel | Reporting |
Two things to know about calcium and phosphorus:
- Hypercalcemia is now a reporting measure. Facilities earn credit by reporting total uncorrected calcium in EQRS. The older clinical version scored the percentage of patient-months with a 3-month rolling average uncorrected calcium above 10.2 mg/dL, and the CMS survey tool still lists that value. CMS specifies uncorrected calcium to avoid differences between albumin-correction formulas.
- Proposed change: the CY 2027 ESRD PPS proposed rule (June 2026) would replace the Hypercalcemia reporting measure with a Facility-Level Percentage of Chronic Hyperphosphatemia clinical measure starting in PY 2029, and would remove the MedRec and COVID-19 vaccination reporting measures. Treat this as proposed, not final, until CMS issues the final rule.
The CY 2026 rule also removed three health-equity and social-drivers reporting measures starting in PY 2027. CMS ended the ESRD Treatment Choices payment model on December 31, 2025.
QAPI versus ESRD QIP at a glance
| Feature | QAPI (§494.110) | ESRD QIP (section 1881(h)) |
|---|---|---|
| Purpose | Internal, continuous improvement | Payment incentive and public accountability |
| Who sets the measures | Facility, covering the required indicator areas | CMS, through annual rulemaking |
| Consequence | Survey deficiencies if the program is ineffective | Payment reduction of up to 2% |
| Data | Facility data, Network goals, Dialysis Facility Reports | EQRS, NHSN, claims and survey data |
Mandated by Section 153(c) of the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008, the End-Stage Renal Disease Quality Incentive Program (ESRD QIP) links Medicare reimbursement directly to dialysis clinic performance. What is the maximum statutory reimbursement penalty that CMS can assess against an underperforming dialysis facility, and how is this penalty applied?
A civil monetary penalty of up to $50,000 levied against the operating license of the dialysis provider.
A mandatory 5.0% forfeiture of all physician medical director payments for the subsequent operating fiscal year.
A 10.0% reduction in laboratory and injectable drug reimbursements while preserving the core dialysis composite payment rate.
A payment reduction of up to 2.0% applied across all Medicare Prospective Payment System (PPS) reimbursement claims for the applicable payment year.
A facility's QAPI committee prepares for the PY 2028 ESRD Quality Incentive Program. Which statement correctly describes the Hypercalcemia measure in that measure set?
It is a reporting measure that credits facilities for reporting a total uncorrected serum or plasma calcium value in EQRS for each patient-month.
It is a clinical measure scoring the share of patients whose albumin-corrected calcium exceeds 10.5 mg/dL on a single draw.
It measures the share of treatments using dialysate calcium above 3.0 mEq/L.
It counts new calciphylaxis cases among patients taking calcium-based binders.
A renal dietitian notes during monthly QAPI surveillance that 34% of the clinic's hemodialysis patients have a serum phosphorus level exceeding 7.0 mg/dL. To address this clinical shortfall, the dietitian initiates a Quality Improvement initiative using the Plan-Do-Study-Act (PDSA) framework. Which action represents the "Do" phase of this cycle?
Convening the interdisciplinary team to brainstorm root causes using an Ishikawa fishbone diagram and establishing a target of reducing hyperphosphatemia to under 20%.
Piloting a structured mealtime phosphate binder administration visual coaching protocol with the Tuesday-Thursday-Saturday morning shift over a 4-week trial while recording adherence observations.
Analyzing serum phosphorus lab trends at the conclusion of the 4-week pilot to determine whether the intervention achieved the target 14% absolute reduction.
Adopting the visual coaching protocol into the facility's standard operating procedure across all shifts and presenting the final outcomes at the regional corporate quality forum.
Sections you finish are checked off in the contents.